Stay updated on Talimogene Laherparepvec and Nivolumab Combination Clinical Trial
Sign up to get notified when there's something new on the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page.
Latest updates to the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page
- Check6 days agoChange DetectedMajor study details such as objectives, endpoints, eligibility criteria, and enrollment appear unchanged; only formatting tweaks and a timestamp update are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check13 days agoChange DetectedNon-significant changes observed: the page's update timestamp was refreshed and minor layout adjustments were made, with no changes to eligibility, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check20 days agoChange DetectedThe page revision has been updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check27 days agoChange DetectedRemoved the government funding status notice from the page, which previously directed users to opm.gov for operating status updates. No trial content, eligibility criteria, or results were modified.SummaryDifference0.3%
- Check42 days agoChange DetectedOnly metadata and update timestamps on the Study Details page were refreshed; core study content, eligibility, endpoints, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check49 days agoChange DetectedThe page shows only non-substantive changes such as formatting updates and a new last update timestamp; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
Stay in the know with updates to Talimogene Laherparepvec and Nivolumab Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page.